P-Anisidine → HCID 22557950, 화합물

HRID 984178노트

반응식

HRID 984178 반응식
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C:15]2[CH:20]=[C:19]([CH2:21][N:22]3[CH2:27][CH2:26][C:25](=O)[CH2:24][CH2:23]3)[CH:18]=[CH:17][N:16]=2)[CH:6]=[C:7]([O:13][CH3:14])[C:8]=1[O:9][CH:10]([CH3:12])[CH3:11].[CH3:29][O:30][C:31]1[CH:36]=[CH:35][C:34]([NH2:37])=[CH:33][CH:32]=1>>[CH3:29][O:30][C:31]1[CH:36]=[CH:35][C:34]([NH:37][CH:25]2[CH2:26][CH2:27][N:22]([CH2:21][C:19]3[CH:18]=[CH:17][N:16]=[C:15]([C:5]4[CH:6]=[C:7]([O:13][CH3:14])[C:8]([O:9][CH:10]([CH3:11])[CH3:12])=[C:3]([O:2][CH3:1])[CH:4]=4)[CH:20]=3)[CH2:23][CH2:24]2)=[CH:33][CH:32]=1

참가 물질

3

반응물 2

HCID 7732P-AnisidineHCID 22557797HCID 22557797, 화합물

생성물 1

HCID 22557950HCID 22557950, 화합물

실험 절차

1-[[2-(3,5-dimethoxy-4-isopropoxyphenyl)pyridin-4-yl]methyl]-4-piperidone (350 mg) and p-anisidine (123 mg) were condensed in the same manner as described in Preparation Example 37 to give the title compound.

후처리

  1. customcondensed in the same manner
  2. customas described in Preparation Example 37

출처 및 근거

ORD 기록
ord-6f57ce85fff54ccbb4ae9408ff641470
출처 데이터셋
uspto-grants-2005_03
특허 번호
US06867221B2

반응 노트

불러오는 중…